{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:38:56Z","timestamp":1792237136092,"version":"4.4.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["Industrial Doctorate grant 00002\/2023"],"award-info":[{"award-number":["Industrial Doctorate grant 00002\/2023"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>A comprehensive understanding of drug metabolism is crucial for advancements in drug development. Automation has improved various stages of this process, from compound procurement to data analysis, but significant challenges persist in the metabolite identification (MetID) of macromolecules due to their size, structural complexity, and associated computational demands. This study introduces new algorithms for automated Liquid Chromatography-High-Resolution Mass Spectrometry (LC-HRMS) data analysis applicable to macromolecules. A novel peak detection approach based on the most abundant mass (MaM) is presented and systematically compared with the monoisotopic mass (MiM) approach, commonly used in small molecules MetID. Additionally, three structure visualization strategies, expanded (atom-level), non-expanded (monomer-level), and a hybrid mode, are evaluated for their impact on computation data processing time and interpretability, based on their distinct fragmentation strategies. The workflow was validated using six diverse datasets, comprising linear and cyclic peptides and oligonucleotides with both natural and unnatural monomers, covering a molecular weight range of 700\u20137630 Da. A total of 970 metabolites were identified under various experimental and ionization conditions. The MaM algorithm demonstrated higher scores and a greater number of matches, instilling greater confidence in the accurate prediction of metabolite structures, while the non-expanded visualization significantly reduced processing times (ranging from minutes to under an hour for most peptides). Furthermore, the visualization algorithm, which integrates monomer-level and atom\/bond notation, enables clear localization of metabolic biotransformations. Compared to previous studies, the proposed workflow demonstrated reduced processing time, consistent detection of degradation products, and enhanced visualization capabilities, advancing automated MetID for macromolecules.<\/jats:p>","DOI":"10.1371\/journal.pone.0324668","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:23:13Z","timestamp":1755109393000},"page":"e0324668","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["An automated software-assisted approach for exploring metabolic susceptibility and degradation products in macromolecules using high-resolution mass spectrometry"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8181-8822","authenticated-orcid":true,"given":"Paula","family":"Cifuentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Radchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Garriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Morettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Kammersgaard","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Helleberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"pone.0324668.ref001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/B978-0-12-820018-6.00004-1","article-title":"Methods for metabolite generation and characterization by NMR","author":"L Evans","year":"2020","journal-title":"Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Elsevier"},{"issue":"11","key":"pone.0324668.ref002","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/1389200222666211006104502","article-title":"Metabolite Identification in the Preclinical and Clinical Phase of Drug Development","volume":"22","author":"Y Wu","year":"2021","journal-title":"Curr Drug Metab"},{"issue":"1","key":"pone.0324668.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2008.11.013","article-title":"Overview: Evaluation of metabolism-based drug toxicity in drug development","volume":"179","author":"AP Li","year":"2009","journal-title":"Chem Biol Interact"},{"key":"pone.0324668.ref004","first-page":"329","article-title":"Analyzing drug metabolism: a key factor in drug development and safety assessment","volume":"15","author":"J Kania","year":"2024","journal-title":"J Drug Metab Toxicol"},{"issue":"1","key":"pone.0324668.ref005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"L Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"pone.0324668.ref006","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/pharmaceutics14020260","article-title":"Oligonucleotide Therapeutics: From Discovery and Development to Patentability","volume":"14","author":"L Moumn\u00e9","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"pone.0324668.ref007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4155\/bio.11.333","article-title":"Identifying metabolite ions of peptide drugs in the presence of an in vivo matrix background","volume":"4","author":"F Cuyckens","year":"2012","journal-title":"Bioanalysis"},{"key":"pone.0324668.ref008","unstructured":"Mass Analytica. WebMetabase. 2023."},{"key":"pone.0324668.ref009","unstructured":"Mass Analytica. MassMetaSite. 2023."},{"issue":"11","key":"pone.0324668.ref010","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2174\/1389200219666180628171531","article-title":"Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability","volume":"19","author":"J-F Yao","year":"2018","journal-title":"Curr Drug Metab"},{"issue":"11","key":"pone.0324668.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186461","article-title":"Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry","volume":"12","author":"T Radchenko","year":"2017","journal-title":"PLoS One"},{"key":"pone.0324668.ref012","author":"T Radchenko","year":"2018"},{"issue":"12","key":"pone.0324668.ref013","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.3390\/molecules181214564","article-title":"Insights into structure-activity relationships of somatostatin analogs containing mesitylalanine","volume":"18","author":"P Mart\u00edn-Gago","year":"2013","journal-title":"Molecules"},{"key":"pone.0324668.ref014","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.omtn.2020.07.012","article-title":"Introducing an in vitro liver stability assay capable of predicting the in vivo pharmacodynamic efficacy of siRNAs for IVIVC","volume":"21","author":"B Basiri","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"pone.0324668.ref015","doi-asserted-by":"crossref","first-page":"114518","DOI":"10.1016\/j.jpba.2021.114518","article-title":"Automated high-throughput in vitro assays to identify metabolic hotspots and protease stability of structurally diverse, pharmacologically active peptides for inhalation","volume":"211","author":"F Wesche","year":"2022","journal-title":"J Pharm Biomed Anal"},{"issue":"21","key":"pone.0324668.ref016","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1074\/jbc.M900068200","article-title":"Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme","volume":"284","author":"M Manolopoulou","year":"2009","journal-title":"J Biol Chem"},{"issue":"21","key":"pone.0324668.ref017","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/rcm.4753","article-title":"Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation","volume":"24","author":"B Bonn","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"2","key":"pone.0324668.ref018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/rcm.7429","article-title":"Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery","volume":"30","author":"EN Cece-Esencan","year":"2016","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"10","key":"pone.0324668.ref019","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.4155\/bio.13.89","article-title":"Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery","volume":"5","author":"V Zelesky","year":"2013","journal-title":"Bioanalysis"},{"issue":"14","key":"pone.0324668.ref020","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1016\/j.jprot.2012.04.009","article-title":"Mass spectrometry and animal science: protein identification strategies and particularities of farm animal species","volume":"75","author":"R Soares","year":"2012","journal-title":"J Proteomics"},{"issue":"12","key":"pone.0324668.ref021","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.8792","article-title":"Metabolite identification using an ion mobility enhanced data-independent acquisition strategy and automated data processing","volume":"34","author":"T Radchenko","year":"2020","journal-title":"Rapid Commun Mass Spectrom"},{"key":"pone.0324668.ref022","unstructured":"Mass Analytica. https:\/\/mass-analytica.com\/products\/webchembase\/chromatography-quality-and-multiple-signal-detection\/. Accessed 2024 February 26."},{"key":"pone.0324668.ref023","first-page":"846","article-title":"Peak shapes and their measurements: the need and the concept behind total peak shape analysis","volume":"12","author":"M Wahab","year":"2017","journal-title":"LC GC North Am"},{"issue":"3","key":"pone.0324668.ref024","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/jm500810s","article-title":"Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications","volume":"58","author":"B Manandhar","year":"2015","journal-title":"J Med Chem"},{"key":"pone.0324668.ref025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2017.03.020","article-title":"Absorption, metabolism and excretion of the GLP-1 analogue semaglutide in humans and nonclinical species","volume":"104","author":"L Jensen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"pone.0324668.ref026","author":"MD Wrona","year":"2019"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:23:21Z","timestamp":1755109401000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324668"}},"subtitle":[],"editor":[{"given":"Yash","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0324668","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}